Clinical Trials

Dr. Young’s clinical trial network in Hong Kong has started Phase 2 clinical trials!  This trial is looking at the safety of escalating doses of injections of umbilical cord blood mononuclear cells into the spinal cord, with four people at each level.  At each level, patients are observed for potential side effects.  In the final step of Phase 2, participants will be given the highest safe dose of cord blood stem cells plus a six-week course of oral lithium.

Seven patients already have been treated with no significant problems.  Some have reported increased sensation and some recovery of function!  However, definitive results won’t be known until the independent examinations are conducted.

This Phase 2 Trial will be repeated in the fall in Kunming, China.  In Kunming it will be accompanied by intense physical therapy, the so-called '6-6-6' program: six hours a day, six days a week, for six months.

The data from these trials will be submitted to the FDA for clinical trials in the United States.  In September we will be meeting with people at our flagship hospital in Austin, Texas to continue planning there.

Click here to watch a video of Dr. Young explaining, ‘Why Umbilical Cord Stem Cells’